Enovix Corporation vs iShares MSCI China ETF — how do they compare? Enovix Corporation trades at $2.41 (market cap $549.72M), while iShares MSCI China ETF trades at $52.44 (market cap $5.94B). The key difference: iShares MSCI China ETF is far larger — about 10.8× Enovix Corporation's market cap, and iShares MSCI China ETF is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and iShares MSCI China ETF for 63 Days on average.
| ENVX | MCHI | |
|---|---|---|
Market Cap | $549.72M | $5.94B |
Volume | 6,635,687 | 1,575,471 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $13.19 | $65.59 |
52-Week Low | $2.50 | $50.48 |
Typical Hold Time | 11 Days | 63 Days |
Enterprise Value | $611.42M | — |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.46, down 3.53% on the day, reflecting a bearish technical trend. The company is in a high-growth investment phase, with revenue growing to $36 million in 2026 but reporting significant losses. Recent news highlights a CEO transition and progress in battery manufacturing for defense and consumer electronics, while analyst consensus remains largely positive with a $10.75 price target.
The outlook is bifurcated: strong analyst buy ratings and institutional interest signal long-term potential, but high cash burn, persistent losses, and bearish technical indicators present substantial near-term risks. Investment hinges on successful commercialization and achieving profitability from current expansion efforts.
MCHI trades at $52.45, up 1.57% with a bearish technical outlook as moving averages signal strong selling pressure. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent news highlights mixed signals with corporate profits surging 26% in Q2 2026 while exports face global pushback. Institutional activity shows conflicting positions with Empowered Funds acquiring shares while Acima Private Wealth reduced holdings.
The outlook remains cautious given China's macroeconomic pressures and trade tensions. Investment opportunity exists in the significant discount to historical valuations, but risks include potential export controls, protectionism threats, and ongoing economic rebalancing challenges that could pressure Chinese equities.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →